#FH25 Beyond the Obvious: Molecular Medicine as it is Now - Part C
Convergence of life sciences, biotech, AI, and digital health. This is where biomedicine and health meet digital, and where the future of healthcare is being redefined through cross-disciplinary innovation and the rise of emerging tech. The second part of the session will dive into the evolving landscape of technology transfer, molecular medicine, and the integration of AI in biomedical research, highlighting how these forces are driving the next wave of scientific breakthroughs and reshaping the innovation pipeline.
C. Panel Discussion
Moderator: Nana Bit-Avragim
- Andreas Busch, Absci
- Janna Hachmann, Captain T Cell
- Christopher Rudolf, Volv Global
- Monika Swietlicka, Halloran Consultancy